Image may be NSFW.
Clik here to view.
Voluntis has inked a commercial deal to combine its insulin titration tech with WellDoc‘s coaching platform to create a digital management solution for people with Type II diabetes.
Cambridge, Mass.-based Voluntis has developed an FDA-approved system, Insulia, which provides automated insulin dose recommendations that can be monitored remotely by a patient’s healthcare team. WellDoc’s BlueStar program gives real-time, individualized coaching to people with Type II diabetes.
Get the full story at our sister site, Drug Delivery Business News.
The post Voluntis, WellDoc partner to offer digital diabetes management system appeared first on MassDevice.
